Atlas Trials

Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

Clinical trial NCT06525675 · COMPLETED

Trial details

NCT number
NCT06525675
Sponsor
MedSIR
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Breast CancerAdvanced Breast CancerLuminal Breast CancerHER2-negative Breast CancerER-positive Breast Cancer
Start date
2022-07-18
Primary completion
2024-05-26
Enrollment
419

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.